Kuros (company)

Kuros Biosciences is a Swiss-based biotechnology company focused on the development, manufacturing, and commercialization of innovative products for tissue repair and regeneration. The company's proprietary technology platforms are designed to promote natural healing processes in orthopedic, wound care, and spinal fusion applications.

Kuros develops biomaterials based on a unique combination of biopolymers and growth factors. Its lead products often center around bone graft substitutes intended to improve bone regeneration in spinal fusions and trauma surgeries. The company's strategic focus includes addressing unmet clinical needs with solutions designed to enhance patient outcomes and simplify surgical procedures.

Kuros Biosciences is publicly traded. The company has partnerships with other organizations to expand its reach and product offerings within the regenerative medicine field. The name "Kuros" itself is intended to reflect the company's commitment to a curative or restorative approach to healthcare.